Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Shares Issued (2020 - 2024)

Relay Therapeutics (RLAY) has disclosed Shares Issued for 5 consecutive years, with $218.2 million as the latest value for Q3 2024.

  • Quarterly Shares Issued rose 2221.28% to $218.2 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $244.3 million through Sep 2024, down 16.84% year-over-year, with the annual reading at $17.9 million for FY2024, 40.92% down from the prior year.
  • Shares Issued for Q3 2024 was $218.2 million at Relay Therapeutics, up from $17.9 million in the prior quarter.
  • The five-year high for Shares Issued was $424.1 million in Q4 2020, with the low at -$2.9 million in Q4 2021.
  • Average Shares Issued over 5 years is $63.8 million, with a median of $902000.0 recorded in 2021.
  • The sharpest move saw Shares Issued plummeted 100.69% in 2021, then soared 31463.19% in 2022.
  • Over 5 years, Shares Issued stood at $424.1 million in 2020, then tumbled by 100.69% to -$2.9 million in 2021, then skyrocketed by 59.93% to -$1.2 million in 2022, then surged by 898.64% to $9.4 million in 2023, then skyrocketed by 2221.28% to $218.2 million in 2024.
  • According to Business Quant data, Shares Issued over the past three periods came in at $218.2 million, $17.9 million, and $9.4 million for Q3 2024, Q1 2024, and Q3 2023 respectively.